IntrinsicIntrinsic
← Scroll for more →

Medpace Holdings, Inc. (MEDP)

Services-Commercial Physical & Biological Research

Latest Price
$677.56
TTM P/E
37.60
Normalized P/E
57.65
TTM Div Yield
--
Fwd Div Yield
--
Book Value
20.96
P/B Ratio
32.33

Valuation metrics

adjust assumptions →
EPS: $15.28
Book value / share: $16.18
Formula: √(22.5 × EPS × BVPS)
Graham Number
$74.59
89% downside
Norm. op. income: $279M (median of 7yr)
Tax rate: 15%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$100.99
85% downside
Base FCF: $397M (median of recent 5yr)
Growth: 21%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$817.48
+21% upside
EPS: $15.28
Target P/E: 58×
Formula: EPS × P/E
P/E Fair Value
$886.24
+31% upside

Institutional Ownership

85.6% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.2.50M$1.32B8.93%+27.8K2026-06-30
Price T Rowe Associates Inc2.07M$1.10B7.40%+1.78M2026-06-30
AQR Capital Management LLC1.28M$677.0M4.57%-74.9K2026-06-30
Vanguard Portfolio Management LLC1.13M$600.0M4.05%+11.7K2026-06-30
Vanguard Capital Management LLC1.03M$543.0M3.67%+15.7K2026-06-30
State Street Corp710.9K$376.0M2.54%+28.7K2026-06-30
Geode Capital Management, LLC710.5K$376.0M2.54%-34.6K2026-06-30
Wasatch Advisors LP636.6K$337.0M2.28%-137.3K2026-06-30
Invesco Ltd.579.2K$306.0M2.07%+1.7K2026-06-30
Baillie Gifford & Co473.2K$250.0M1.69%-30.0K2026-06-30
View all institutional holders →